Trade Summary

6 months ago, Bailey Gregory, serving as Dir at Biohaven Ltd. (BHVN), purchased 400,000 shares at $7.50 per share, for a total transaction value of $3,000,000.00. Following this transaction, Bailey Gregory now holds 2,020,071 shares of BHVN.

This purchase represents a 25.00% increase in Bailey Gregory's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, November 13, 2025 and publicly disclosed via SEC Form 4 filing on Monday, November 17, 2025 at 7:31 AM ET, 4 days after the trade was made.

Biohaven Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.